Mpox vaccine is safe and generates a robust antibody response in adolescents, study finds

A National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a planned interim analysis of study data. Adolescents are among the population groups affected by…

Click here to view the original article.